Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven for Renal Function in Aortic Valve Replacement (SHARP)
NCT02192502Phase 3Completed
- Sponsor
- Cleveland Clinic
- Start
- Mar 2015
- Primary completion
- Feb 2018
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Volulyte in Postoperative acute kidney injury (PO-AKI), sponsored by Cleveland Clinic. Started Mar 2015; status: completed.
02
Drugs
Volulyte
03
Conditions
Postoperative acute kidney injury (PO-AKI)
Beyond the preview
Go deeper on NCT02192502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192502.